Erik Amble

Erik Amble is the chairman and founder of NeoMed Management in 1997. Prior to that, he has been chairman and controlling shareholder of NeoMed AS, providing investment advisory services, specialising in small and medium sized companies in the pharmaceutical, medical device and diagnostic industries. From 1993 to 1997, NeoMed AS co-managed two private equity investment companies, KS Nordic Healthcare Partners and Viking Medical Ventures Limited.

Erik Amble has served as a board member of a. o. Clavis Pharma AS, GenoVision AS, InDex Pharmaceuticals AB, Thommen Medical AG and Vessix Vascular Inc. and currently serves on various Board of Directors.

Go back